EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis

Zhaohui Liao Arter, Joo Sung Gabriel Shim, Cathleen Park, Sarah Waliany, Sun Min Lim, Ross A Soo

Cancer Treatment Reviews · 2026-11 · 150 · 103204

DOI: 10.1016/j.ctrv.2026.103204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Zhaohui Liao Arter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, University of California Irvine School of Medicine, United States of America. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Purine-Nucleoside Phosphorylase, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesPurine-Nucleoside PhosphorylaseLung NeoplasmsCarcinoma, Non-Small-Cell LungMethionine AdenosyltransferaseHumansMolecular Targeted TherapyAnimals

Stichwörter der Autor:innen

BiomarkersMAT2AMTAPNSCLCPRMT5Precision oncologySynthetic lethality

Substanzen

Protein-Arginine N-MethyltransferasesPurine-Nucleoside PhosphorylasePRMT5 protein, human5'-methylthioadenosine phosphorylaseMAT2A protein, humanMethionine Adenosyltransferase

Autor:innen und Institutionen

  • Division of Hematology-Oncology, University of California Irvine School of Medicine, United States of America.
  • Division of Medical Oncology, Yonsei University College of Medicine, United States of America.
  • Division of Oncology, Mass General Brigham Cancer Institute, Boston, MA, United States of America.
  • Department of Hematology-Oncology, National University Hospital, Singapore. Electronic address: ross_soo@nuhs.edu.sg.

Zitieren

APA

Arter, Z. L., Shim, J. S. G., Park, C., Waliany, S., Lim, S. M., & Soo, R. A. (2026). MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis. Cancer Treatment Reviews, 150, 103204. https://doi.org/10.1016/j.ctrv.2026.103204

Vancouver

Arter ZL, Shim JSG, Park C, Waliany S, Lim SM, Soo RA. MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis. Cancer Treatment Reviews. 2026;150:103204. doi:10.1016/j.ctrv.2026.103204

BibTeX
@article{Arter2026,
  author = {Arter, Zhaohui Liao and Shim, Joo Sung Gabriel and Park, Cathleen and Waliany, Sarah and Lim, Sun Min and Soo, Ross A},
  title = {MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {150},
  pages = {103204},
  doi = {10.1016/j.ctrv.2026.103204}
}
Kostenlos starten →